Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topical minocycline-impregnated collagen plug to prevent MRONJ after tooth extraction
jRCTs071220088Recruiting
- Sponsor
- GC Biopharma Corp
- Start
- Jan 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Trial of minocycline in medication-related osteonecrosis of the jaw (MRONJ), sponsored by GC Biopharma Corp. Primary endpoint: MRONJ onset rate at 2 months. Started Jan 2023; status: recruiting.
02
Drugs
minocycline
03
Conditions
medication-related osteonecrosis of the jaw (MRONJ)
Beyond the preview
Go deeper on jRCTs071220088.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs071220088.